117 related articles for article (PubMed ID: 36350049)
1. Leveraging the Clinical Timepoints in Lung Cancer Screening to Engage Individuals in Tobacco Treatment.
Park ER; Neil JM; Noonan E; Howard SE; Gonzalez I; Marotta C; Wint AJ; Levy DE; Chang Y; Rigotti NA; Haas JS
JNCI Cancer Spectr; 2022 Nov; 6(6):. PubMed ID: 36350049
[TBL] [Abstract][Full Text] [Related]
2. Integrating tobacco treatment into lung cancer screening practices: Study protocol for the Screen ASSIST randomized clinical trial.
Neil JM; Marotta C; Gonzalez I; Chang Y; Levy DE; Wint A; Harris K; Hawari S; Noonan E; Styklunas G; Crute S; Howard SE; Sheppard J; Lennes IT; Jacobson F; Flores EJ; Haas JS; Park ER; Rigotti NA
Contemp Clin Trials; 2021 Dec; 111():106586. PubMed ID: 34606988
[TBL] [Abstract][Full Text] [Related]
3. Accelerating integration of tobacco use treatment in the context of lung cancer screening: Relevance and application of implementation science to achieving policy and practice.
Shelley D; Wang VH; Taylor K; Williams R; Toll B; Rojewski A; Foley KL; Rigotti N; Ostroff JS
Transl Behav Med; 2022 Nov; 12(11):1076-1083. PubMed ID: 36227937
[TBL] [Abstract][Full Text] [Related]
4. The Optimizing Lung Screening Trial (WF-20817CD): Multicenter Randomized Effectiveness Implementation Trial to Increase Tobacco Use Cessation for Individuals Undergoing Lung Screening.
Foley KL; Dressler EV; Weaver KE; Sutfin EL; Miller DP; Bellinger C; Kittel C; Stone RJ; Petty WJ; Land SR; Spangler JG; Lesser GJ; Chiles C;
Chest; 2023 Aug; 164(2):531-543. PubMed ID: 36931460
[TBL] [Abstract][Full Text] [Related]
5. Study protocol for a telephone-based smoking cessation randomized controlled trial in the lung cancer screening setting: The lung screening, tobacco, and health trial.
Taylor KL; Deros DE; Fallon S; Stephens J; Kim E; Lobo T; Davis KM; Luta G; Jayasekera J; Meza R; Stanton CA; Niaura RS; Abrams DB; McKee B; Howell J; Ramsaier M; Batlle J; Dornelas E; Parikh V; Anderson E
Contemp Clin Trials; 2019 Jul; 82():25-35. PubMed ID: 31129371
[TBL] [Abstract][Full Text] [Related]
6. An integrated digital/clinical approach to smoking cessation in lung cancer screening: study protocol for a randomized controlled trial.
Graham AL; Burke MV; Jacobs MA; Cha S; Croghan IT; Schroeder DR; Moriarty JP; Borah BJ; Rasmussen DF; Brookover MJ; Suesse DB; Midthun DE; Hays JT
Trials; 2017 Nov; 18(1):568. PubMed ID: 29179734
[TBL] [Abstract][Full Text] [Related]
7. Perceptions and Utilization of Lung Cancer Screening Among Smokers Enrolled in a Tobacco Cessation Program.
Raz DJ; Wu G; Nelson RA; Sun V; Wu S; Alem A; Haupt EC; Ismail MH; Gould MK
Clin Lung Cancer; 2019 Jan; 20(1):e115-e122. PubMed ID: 30585165
[TBL] [Abstract][Full Text] [Related]
8. Predictors of attrition in a smoking cessation trial conducted in the lung cancer screening setting.
Kim E; Williams RM; Eyestone E; Cordon M; Smith L; Davis K; Luta G; Anderson ED; McKee B; Batlle J; Ramsaier M; Howell J; Parikh V; Geronimo M; Stanton C; Niaura R; Abrams D; Taylor KL;
Contemp Clin Trials; 2021 Jul; 106():106429. PubMed ID: 33964415
[TBL] [Abstract][Full Text] [Related]
9. Screening Mammography Visits as Opportunities to Engage Smokers With Tobacco Cessation Services and Lung Cancer Screening.
Wang GX; Narayan AK; Park ER; Lehman CD; Gorenstein JT; Flores EJ
J Am Coll Radiol; 2020 May; 17(5):606-612. PubMed ID: 31930983
[TBL] [Abstract][Full Text] [Related]
10. Predictors of Enrollment of Older Smokers in Six Smoking Cessation Trials in the Lung Cancer Screening Setting: The Smoking Cessation at Lung Examination (SCALE) Collaboration.
Eyestone E; Williams RM; Luta G; Kim E; Toll BA; Rojewski A; Neil J; Cinciripini PM; Cordon M; Foley K; Haas JS; Joseph AM; Minnix JA; Ostroff JS; Park E; Rigotti N; Sorgen L; Taylor KL
Nicotine Tob Res; 2021 Nov; 23(12):2037-2046. PubMed ID: 34077535
[TBL] [Abstract][Full Text] [Related]
11. The tobacco quitline setting as a teachable moment: The Educating Quitline Users About Lung (EQUAL) cancer screening randomized trial.
Webster M; Whealan J; Williams RM; Eyestone E; Le A; Childs J; Kao JY; Martin M; Wolfe S; Yang F; Hung PY; Lau YK; Luta G; Tammemagi M; Meza R; Taylor KL
Transl Behav Med; 2023 Sep; 13(10):736-747. PubMed ID: 37616531
[TBL] [Abstract][Full Text] [Related]
12. Study protocol of a multiphase optimization strategy trial (MOST) for delivery of smoking cessation treatment in lung cancer screening settings.
Ostroff JS; Shelley DR; Chichester LA; King JC; Li Y; Schofield E; Ciupek A; Criswell A; Acharya R; Banerjee SC; Elkin EB; Lynch K; Weiner BJ; Orlow I; Martin CM; Chan SV; Frederico V; Camille P; Holland S; Kenney J
Trials; 2022 Aug; 23(1):664. PubMed ID: 35978334
[TBL] [Abstract][Full Text] [Related]
13. Augmented meaningful use criteria to identify patients eligible for lung cancer screening.
Raz DJ; Dunham R; Tiep B; Sandoval A; Grannis F; Rotter A; Kim JY
Ann Thorac Surg; 2014 Sep; 98(3):996-1002. PubMed ID: 25063304
[TBL] [Abstract][Full Text] [Related]
14. Improving Utilization of Lung Cancer Screening Through Incorporating a Video-Based Educational Tool Into Smoking Cessation Counseling.
Raz DJ; Ismail MH; Haupt EC; Sun V; Park S; Alem AC; Gould MK
Clin Lung Cancer; 2021 Mar; 22(2):83-91. PubMed ID: 33436279
[TBL] [Abstract][Full Text] [Related]
15. Development and Evaluation of Brief Web-Based Education for Primary Care Providers to Address Inequities in Lung Cancer Screening and Smoking Cessation Treatment.
Smith L; Williams RM; Whealan J; Windels A; Anderson ED; Parikh V; Breece CJ; Puran N; Shepherd AK; Geronimo M; Luta G; Adams-Campbell L; Taylor KL
J Cancer Educ; 2023 Aug; 38(4):1296-1303. PubMed ID: 36637713
[TBL] [Abstract][Full Text] [Related]
16. Lung Cancer Screening Eligibility, Risk Perceptions, and Clinician Delivery of Tobacco Cessation Among Patients With Schizophrenia.
Irwin KE; Steffens EB; Yoon Y; Flores EJ; Knight HP; Pirl WF; Freudenreich O; Henderson DC; Park ER
Psychiatr Serv; 2019 Oct; 70(10):927-934. PubMed ID: 31357921
[TBL] [Abstract][Full Text] [Related]
17. Assessing Eligibility for Lung Cancer Screening Among Women Undergoing Screening Mammography: Cross-Sectional Survey Results From the National Health Interview Survey.
López DB; Flores EJ; Miles RC; Wang GX; Glover M; Shepard JO; Lehman CD; Narayan AK
J Am Coll Radiol; 2019 Oct; 16(10):1433-1439. PubMed ID: 31092347
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of Proactive Tobacco Cessation Treatment Outreach Among Smokers With Serious Mental Illness.
Japuntich SJ; Hammett PJ; Rogers ES; Fu S; Burgess DJ; El Shahawy O; Melzer AC; Noorbaloochi S; Krebs P; Sherman SE
Nicotine Tob Res; 2020 Aug; 22(9):1433-1438. PubMed ID: 31957794
[TBL] [Abstract][Full Text] [Related]
19. Proactive tobacco treatment and population-level cessation: a pragmatic randomized clinical trial.
Fu SS; van Ryn M; Sherman SE; Burgess DJ; Noorbaloochi S; Clothier B; Taylor BC; Schlede CM; Burke RS; Joseph AM
JAMA Intern Med; 2014 May; 174(5):671-7. PubMed ID: 24615217
[TBL] [Abstract][Full Text] [Related]
20. Population-based tobacco treatment: study design of a randomized controlled trial.
Fu SS; van Ryn M; Sherman SE; Burgess DJ; Noorbaloochi S; Clothier B; Joseph AM
BMC Public Health; 2012 Mar; 12():159. PubMed ID: 22394386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
